Literature DB >> 22512851

Emerging clinico-epidemiological trends in melioidosis: analysis of 95 cases from western coastal India.

K Vidyalakshmi1, S Lipika, S Vishal, S Damodar, M Chakrapani.   

Abstract

OBJECTIVES: To study the clinico-epidemiological trends in melioidosis, an emerging disease in the western coastal region of India.
METHODS: Data of 95 patients with melioidosis in the western coastal region of India were retrospectively analyzed with respect to monthly rainfall, risk factors, clinical presentations, and outcome.
RESULTS: A strong linear correlation was seen between average monthly rainfall and the occurrence of cases (p=0.002). Mortality was seen only in patients with bacteremia (p<0.001). Nine (40.9%) patients with septic shock died (p<0.001). Age ≥ 40 years and diabetes mellitus were seen in 75.8% of cases, each. Pneumonia was the most common clinical presentation (32.6%), followed by musculoskeletal disease (20%), melioidotic lymphadenopathy (7.4%), and dental abscess (6.3%). Only 36.8% of patients had exposure to wet soil/surface water.
CONCLUSIONS: Melioidosis is quite prevalent in the western coastal region of India, and is strongly associated with rainfall, age, and diabetes mellitus. Higher proportions of musculoskeletal, dental, and lymph node melioidosis were seen in this region as compared to endemic areas. Bacteremic melioidosis has a poorer prognosis than non-bacteremic melioidosis. The presence of septic shock is a strong predictor of mortality. Percutaneous inoculation may not be the main portal of entry for Burkholderia pseudomallei in this region.
Copyright © 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22512851     DOI: 10.1016/j.ijid.2012.02.012

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  34 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

Review 2.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

3.  Melioidosis presenting as Fever and jaundice: a rare presentation.

Authors:  Pankaj Tyagi; Vinit Shah; Praveen Sharma; Naresh Bansal; Vikas Singla; Ashish Kumar; Anil Arora
Journal:  J Clin Exp Hepatol       Date:  2013-10-25

4.  Melioidosis of the Musculoskeletal System.

Authors:  Rajamani Perumal; Abel Livingston; Sumant Samuel; Santhosh Kumar Govindaraju
Journal:  Med Princ Pract       Date:  2019-09-02       Impact factor: 1.927

5.  Cutaneous Melioidosis.

Authors:  Basavaprabhu Achappa; Deepak Madi; K Vidyalakshmi
Journal:  J Clin Diagn Res       Date:  2016-09-01

6.  Gastrointestinal manifestations of melioidosis: A single center experience.

Authors:  Nitin Jagtap; Harshal Shah; Anuradha Kancharla; Manu Tandan; Partha Pal; Sundeep Lakhtakia; Mohan Ramchandani; D N Reddy
Journal:  Indian J Gastroenterol       Date:  2017-03-29

7.  Septicaemic melioidosis: case report from a non-endemic area.

Authors:  Smita Sood; Raghuvir Singh Khedar; Shabbar Hk Joad; Rajeev Gupta
Journal:  J Clin Diagn Res       Date:  2014-12-05

8.  Musculoskeletal melioidosis: An under-diagnosed entity in developing countries.

Authors:  Hitendra G Patil; Manit Gundavda; Vivek Shetty; Rajeev Soman; Camilla Rodriques; Vikas M Agashe
Journal:  J Orthop       Date:  2015-09-19

Review 9.  The art of persistence-the secrets to Burkholderia chronic infections.

Authors:  Eric R G Lewis; Alfredo G Torres
Journal:  Pathog Dis       Date:  2016-07-19       Impact factor: 3.166

10.  Successful Treatment of Chromobacterium violaceum Sepsis in a South Indian Adult.

Authors:  Deepak R Madi; K Vidyalakshmi; John Ramapuram; Avinash K Shetty
Journal:  Am J Trop Med Hyg       Date:  2015-08-24       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.